KENNETH MANZO
Pharmacy in Shohola, PA

License number
Pennsylvania RPI006981
Category
Pharmacy
Type
Authorization to Administer Injectables
Address
Address
Shohola, PA 18458

Personal information

See more information about KENNETH MANZO at radaris.com
Name
Address
Phone
Kenneth Manzo, age 55
125 Timber Ridge Dr, Shohola, PA 18458
Kenneth Manzo
125 Timber Ridge Dr, Shohola, PA 18458
(570) 296-7952

Professional information

See more information about KENNETH MANZO at trustoria.com
Kenneth Manzo Photo 1
Method Of Treating Lactose Intolerance Using Genetically Engineered Bacteria

Method Of Treating Lactose Intolerance Using Genetically Engineered Bacteria

US Patent:
2009009, Apr 16, 2009
Filed:
Oct 11, 2007
Appl. No.:
11/871113
Inventors:
Kenneth Manzo - Shohola PA, US
Jay Sharma - San Pedro CA, US
International Classification:
A61K 35/74, A61P 1/00
US Classification:
424 932
Abstract:
The present invention relates to genetically engineered bacteria that are able to colonize the mammalian intestine and actively produce mammalian lactase (lactose-phlorizin hydrolase or LPH). This lactose-digesting enzyme is stable and active under the conditions normally found in the mammalian small intestine. Experimental subjects colonized with the genetically engineered bacteria show improved ability to digest lactose in dairy foods.


Kenneth Manzo Photo 2
Method Of Treating Lactose Intolerance Using Genetically Engineered Bacteria

Method Of Treating Lactose Intolerance Using Genetically Engineered Bacteria

US Patent:
2012032, Dec 20, 2012
Filed:
Jul 6, 2012
Appl. No.:
13/543746
Inventors:
Kenneth Manzo - Shohola PA, US
Jay Sharma - Rancho Palos Verdes CA, US
International Classification:
A61K 35/74, A61P 3/00, C12N 15/74, C12N 1/21, A61K 9/19
US Classification:
424490, 4352529, 424 932, 435471
Abstract:
The present invention relates to genetically engineered bacteria that are able to colonize the mammalian intestine and actively produce mammalian lactase (lactose-phlorizin hydrolase or LPH). This lactose-digesting enzyme is stable and active under the conditions normally found in the mammalian small intestine. Experimental subjects colonized with the genetically engineered bacteria show improved ability to digest lactose in dairy foods.